China dietary supplement giant BYHEALTH believes that 2023 could be the “best timing” to reposition its business develop new strategies to succeed in the post-COVID era.
This round-up will look at business updates across APAC’s health and nutrition sector, including a potential MNC acquisition deal for Singapore functional food firm Asmara, financial results of China’s BYHEALTH in the first six months of this year, and...
China health foods giant BYHEALTH reported a 23 per cent slump in its net profit in the first six months of this year, as its brick-and-mortar retail took a hit from renewed lockdowns across the country.
VitamINSIGHTS: Traceability and quality control – Exclusive in-depth analysis
How can traceability technologies safeguard product quality and safety, and to what extent are APAC consumers concerned about these developments? We take a deep dive with Amway, Danone, BYHEALTH and more to find out.
China e-commerce giant JD has released new data on its recent 618 online shopping event, with products from Numans, BYHEALTH, Harbin Pharma the top three bestsellers under the nutrition category.
Nicotinamide adenine dinucleotide (NAD+) loss is more significant in middle-aged men than women, a study funded by China dietary supplement giant BYHEALTH and national R&D institutions has found.
Here we feature the latest exclusive trends insights from major dietary supplement firms, including BYHEALTH’s observations in China, immunity developments in Japan from Kirin, plus key NPD areas from Swisse’s parent company H&H.
BYHEALTH is rebranding its cross-border e-commerce (CBEC) product offerings and has outlined how its new product development and launch plans will peg to the latest trends in China’s supplement market.
China’s largest vitamin and dietary supplement (VDS) firm BYHEALTH is reaping the benefits of an expanding domestic market, as it reported yet another record year of profit and revenue growth.
Global life science business Bioiberica has teamed up with Chinese vitamin and dietary supplements provider ByHealth to expand its joint health product portfolio with the introduction of collagen tablets in China.
